Patent · US Active

Methods and compositions for treating recurrent cancer

US8927019B2 · kind B2 · utility

38Cited by
35References
29Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 2, 2008
Grant dateJan 6, 2015
Priority date
Expiry dateMay 11, 2030

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S977/906
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides methods of treating recurrent cancer (such as recurrent ovarian, peritoneal, or fallopian tube cancer) in an individual, comprising administering to the individual an effective amount of a composition (such as Nab-paclitaxel or Abraxane®) comprising nanoparticles comprising a taxane and a carrier protein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.